Working together to reduce the global burden of kidney cancer
Kidney cancer is a global issue. Every year, 431,000 people worldwide will be diagnosed with kidney cancer.
Click here for shareable information, graphics and materials about kidney cancer for patient organisations worldwide.
Search for IKCC Executive Director Now Open
IKCC is searching for an Executive Director to provide visionary leadership and help ensure the organisation’s mission and objectives are achieved. This role offers a unique opportunity to significantly impact kidney cancer patient care worldwide.
Interested candidates can find more information and apply here. Deadline for applications is 22nd August 2024.
2024 Global Patient Survey
The 2024 IKCC 2024 Global Patient Survey on Kidney Cancer and Growths will launch on 23 September. The survey will have revised and improved questions, as well as new special topic questions on areas of emerging interest. It will be available in 15 languages.
When local efforts are strengthened with a global approach, we can have a great impact on improving the lives of people with kidney cancer.
2024 World Kidney Cancer Day Launched!
World Kidney Cancer Day launched on Thursday 20th June 2024 to great success. The campaign is focused on helping patients and healthcare professionals have better conversations.
The campaign is now live at www.worldkidneycancerday.org where you can find social media content and downloadable resources in 15 languages. Thanks to all Partner Organisations and members of the kidney cancer community who made this year’s campaign a great success!
#WorldKidneyCancerDay24
Tweets from @IKCCorg
;
Pleased to be here with global #kidneycancer advocates from @IKCCorg. Looking fwd to great discussions with fellow advocates, clinicians, and research partners. @myESMO #ESMO24
Early-stage kidney cancer means the cancer has not spread beyond the kidney. Learn about the types of treatments for this stage of kidney cancer in the Early Kidney Cancer Factsheet here: https://ikcc.org/wp-content/uploads/2023/12/5.IKCC_2023_factsheets_RL_EarlyStageKC.pdf
#KidneyCancer #KCSM
Advancements in kidney cancer care, medications, surgical techniques and diagnosis have improved life expectancy for many patients. Learn more in this article from @TIME: #KidneyCancer
What 5 Doctors Are Excited About in Kidney Cancer Research
In the pipeline: targeted medications, a potential vaccine, and more.
time.com
Info ARTuR - X
Nous arrêtons de publier sur notre compte X, mais l'aventure continue !
Suivez-nous pour rester informés dans la lutte contre le #CancerDuRein.
🔹 Instagram : https://www.instagram.com/asso_artur/
🔹 Facebook : https://www.facebook.com/AssoARTuR/
🔹 LinkedIn : https://www.linkedin.com/company/assoartur
HEY YOU!
You're invited to tune in for our FREE annual Virtual Patient Symposium on 9/21! Hear from top #kidneycancer specialists and connect with other members of the kidney cancer community through this all day event. Register here: http://kidneycancer.org/patient-education-events/vps2024/
#VPS24
We are delighted to announce that NICE has issued final draft guidance for use of the HIF-2α inhibitor, belzutifan, for the treatment of people with von Hippel-Lindau (VHL) renal cell carcinoma (RCC) who do not need or want surgery.
Read more here:
https://actionkidneycancer.org/belzutifan-available-on-the-nhs-for-patients-with-vhl-disease/
Did you know?
Kidney cancer is often found by accident.
Kidney cancer is the 14th most prevalent cancer worldwide.
About 59 per cent of kidney cancer cases occur in more developed countries.
Our Global Network
IKCC welcomes every organisation that has an interest in kidney cancer and who pledges to conform to our Code of Conduct. We extend an open invitation to become part of this international network.
Join our mailing list
In the newsletter we highlight news about kidney cancer diagnosis and treatment, and other relevant discussions.